INFORMATION FOR
News
The partnership between Mary Lake Polan, M. D.
An existing, FDA-approved ovarian cancer drug may also treat brain cancers and leukemias that have mutations in the genes IDH1 and IDH2. In a new study, led by Ranjit S.
For women and their doctors, ovarian cancer is “the disease that whispers,” says Yale’s Gil Mor, M. D.